Peter Liu

Founder and CEO, Peter is the driving force behind the commercialisation strategy for OxCAn. Currently finishing a D.Phil in Clinical Medicine (Oxford-Hoffman and Jesus College Graduate Scholar), focusing on oxygen sensing pathway and hepatitis B virus pathogenesis and carcinogenesis. Peter was training in the Doctor of Medicine Program at the University of Toronto (McLaughlin Scholar 2016) and earned his BHSc. Health Sciences, 1st Class from the University of Calgary. Peter is past President of the Oxford University Scientific Society, Director of BRIGHT International, a not-for profit Health Innovation Think Tank, and served as Co-President of the World Health Organization Intern Board while working at the WHO focusing on Essential Medicine and Health Product innovation in non-communicable diseases.